Death penalty foes are calling for an audit of the $54,400 purchase of lethal injection drugs that Nebraska never received.
Sen. Burke Harr of Omaha made the request Thursday in a letter to State Auditor Charlie Janssen. It was released as the anti-death penalty group Retain a Just Nebraska reiterated its arguments that the state is unlikely to execute an inmate again even if voters reinstate the punishment because of challenges obtaining the drugs.
Nebraska bought the drugs from the India-based Harris Pharma LLP but hasn’t been able to import them because of federal restrictions. The state has tried to recoup some of the money, but Harris Pharma has refused to provide a refund.
Sen. Colby Coash of Lincoln says the challenges with executions are a distraction for prison officials.